CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
and safety of T-DXd adjuvant therapy, with or without radiotherapy, post-surgery in anticancer treatment naïve (including neoadjuvant therapy) endometrial...
Phase 3
Bedford, Texas, United States and 85 other locations
study to assess safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of ARR-002 in advanced or metastatic ovarian or endometrial...
Phase 1
Irving, Texas, United States of America and 5 other locations
(MMR) system, that fixes genetic mistakes. In most endometrial cancers, this system works normally, and these cancers are ...
Phase 3
Irving, Texas, United States and 53 other locations
(ON 123300) in combination with the standard daily dose (2.5mg) of letrozole in patients with Recurrent Metastatic Low-grade Endometrioid Endometrial...
Phase 1, Phase 2
Dallas, Texas, United States and 7 other locations
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...
Phase 3
Fort Worth, Texas, United States and 255 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Dallas, Texas, United States and 201 other locations
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...
Phase 2, Phase 3
Fort Worth, Texas, United States and 83 other locations
standard medical care for the treatment of recurrent or progressive endometrial cancer (EC) following prior therapy. There is an eq...
Phase 3
Dallas, Texas, United States and 179 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Dallas, Texas, United States and 168 other locations
The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...
Phase 3
Dallas, Texas, United States and 188 other locations
Clinical trials
Research sites
Resources
Legal